DexCom (DXCM) PT Raised to $450 at Oppenheimer
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $88.76 -1.1%
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 8 | New: 5
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 8 | New: 5
Join SI Premium – FREE
Oppenheimer analyst Steven Lichtman raised the price target on DexCom (NASDAQ: DXCM) to $450.00 (from $445.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Citi Downgrades Lend Lease Group (LLC:AU) (LLESY) to Neutral
- Citi Downgrades FANUC Corp (6954:JP) (FANUY) to Neutral
- argenx SE (ARGX) PT Raised to $1,200 at Citizens on VYVGART Indication Expansion
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
